TINA MCDYESS: Open Payments
NPI 1689393407 · ELLISVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 20 payments from 7 companies in 2025. Trend: 2023 $114 · 2024 $763 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $206 |
| Lundbeck LLC | 4 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Alkermes, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, CAPLYTA.
Industry payments across MS — which companies pay providers there.
